Polatuzumab 是一种带有化疗药物的单克隆抗体。Polatuzumab 靶向CD79b，CD79b 存在于 B 细胞表面。Polatuzumab 粘附在 CD79b 蛋白上并将化疗药物输送到细胞中。然后药物杀死细胞。Polatuzumab 可用于合成 Polatuzumab Vedotin。Polatuzumab Vedotin 是CD79b的抗体药物偶联物 (ADC)。
| 生物活性 | Polatuzumab is a monoclonal antibody, which targetsCD79bthat is found on the surface of B cells. Polatuzumab sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b[1]. |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
